It was also detailed in a report from "*" although hidden in a section on most interesting director purchases 2019. Apparently they also ran a review oct 13 2019. You've probably already heared of these but just in case.
https://unauthorised investment advice/health/dr-borehams-crucible-recce-pharmaceuticals-the-emerging-superbug-killer/
https://unauthorised investment advice/director-trades/the-most-noteworthy-directors-trades-of-2019/
Recce Pharmaceuticals (ASX:RCE), page-43
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
64.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $130.5M | |||
| Open | High | Low | Value | Volume |
| 66.0¢ | 66.0¢ | 64.0¢ | $31.74K | 49.33K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 24674 | 63.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 64.5¢ | 235 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
65.0¢ |
Change
0.000 ( 0.53 %) |
||||
| Open | High | Low | Volume | ||
| 64.5¢ | 65.0¢ | 64.0¢ | 5994 | ||
| Last updated 11.57am 03/05/2024 ? | |||||
| RCE (ASX) Chart |